Menu

Povidone-Iodine

Also known as: PVP-I, Iodopovidone

An antiseptic ingredient whose concentration, vehicle and route matter; surgical skin evidence cannot authorize a homemade nasal or oral preparation.

Gouache still life of an amber bottle and reddish-brown liquid in a glass saucer
Editorial illustration

Povidone-iodine is an antiseptic used in specified skin and other medicinal preparations, not a nutritional iodine substitute. An alcohol-based preparation performed noninferiorly to alcohol-based chlorhexidine in one surgical trial. That result does not clear a skin bottle for eyes, gargling, swallowing or nasal use.1, 2, 3, 4

  • The 2024 surgical trial enrolled 3,360 patients and compared two alcohol-based antiseptic protocols.3
  • The cited 10% first-aid label means 1% available iodine, not 10% elemental iodine.1
  • The separate 0.5% gargle label prohibits swallowing and lists thyroid conditions among its do-not-use warnings.2

What is Povidone-Iodine?

A cited first-aid label lists 10% povidone-iodine with 1% available iodine, while a separate gargle lists 0.5% with 0.05% available iodine. Those numbers refer to different quantities and distinct products. Color alone cannot identify concentration, alcohol content, sterility or an appropriate route.1, 2

Where it comes from

Natural sources

  • No botanical or nutritional-food source is claimed for this medicinal preparation.

How it's made

A formulated povidone-iodine antiseptic material; the actual product and available-iodine specification matter.

What it does in products

  • Active antiseptic in route-specific medicines
  • Professional preoperative skin preparation in specified formulations

Benefits

Evidence for a defined preoperative antisepsis protocol

moderate evidence

The hospital comparison supported noninferiority within its prespecified margin.3

The cluster-randomized crossover trial in three Swiss hospitals found surgical-site infection in 5.1% versus 5.5% with povidone-iodine and chlorhexidine, respectively, both in alcohol. It did not show universal superiority or test an aqueous home first-aid product against no antiseptic.

Evidence scope and limitations

Two specific U.S. labeling examples, one alcohol-based preoperative trial and one FDA warning letter; not every iodine antiseptic or infection indication.

  • Noninferiority in a professional protocol is not superiority or proof of household-product equivalence.
  • First-aid, oral and ophthalmic products cannot be interchanged on ingredient name alone.
  • One label's warnings and available-iodine specification are not a comprehensive monograph for all products.
  • The trial primary abstract was checked; unseen formulation details or subgroup advantages are not asserted.

Evidence last checked: 2026-10-15

Side effects & safety

Irritation or worsening symptoms; exposure beyond the intended route (varies)The first-aid label calls for stopping and obtaining advice if the condition persists or worsens. Its limits do not establish an adverse-event rate for every preparation.

Safety considerations

  • The cited gargle specifically says not to combine it with hydrogen peroxide. That is a product-specific warning, not a complete interaction inventory.
  • Not for: The first-aid solution is external only: avoid eyes and large body areas; deep wounds, bites or serious burns require medical advice.
  • Not for: The gargle label separately excludes thyroid conditions and allergy to its ingredients. Do not assume that a lower percentage removes its restrictions.
  • Not for: Swallowing the first-aid solution requires immediate medical or poison-control advice. Do not convert it into an oral or nasal preparation.
1, 2

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In skincare studies and products

The example labels are 10% first-aid solution and 0.5% gargle, with 1% and 0.05% available iodine respectively. These are label specifications, not a dilution recipe. The surgical study used standardized alcohol-containing preparations and professional application, not a home-mixing protocol.

1, 2, 3

Regulatory status

  • DailyMed supplies specific manufacturer labeling, not a blanket FDA efficacy endorsement. FDA's 2022 Viraldine warning addressed particular nasal/throat products and unsupported COVID-19 claims; it neither approves every antiseptic route nor bans every povidone-iodine preparation.
1, 4

Changing the vehicle or body site changes the evidence question

The surgical experiment kept both antiseptics in alcohol and used professional protocols. Substituting an aqueous bottle, a different body site or a household dilution is an untested change, not a replication of that result.

The FDA letter is another distinct kind of evidence: it challenges specific disease-prevention marketing. A laboratory antimicrobial idea or a familiar active name cannot supply the missing clinical and regulatory support for a nasal claim.

3, 1, 4

Frequently asked questions

Can a first-aid skin solution stand in for an eye preparation or gargle?

No. The skin label excludes eyes, while the separate gargle has its own concentration and warnings. Matching the ingredient name does not establish interchangeability.1, 2

Does the surgical trial prove nasal COVID-19 prevention?

No. Its setting and endpoint were surgical skin preparation and postoperative infection. FDA separately challenged the specified nasal/throat disease claims in its warning letter.3, 4

The bottom line

Match the complete medicine, route and protocol—not just the brown color or iodine percentage—to the evidence and label.

References

  1. Povidone-Iodine Solution, 10%: First Aid Antiseptic Drug Facts. DailyMed / U.S. National Library of Medicine (2026) · ingredient monograph · SPL set ID c2f07152-d7fb-4b1f-be77-c94618d5abd6; version 5, effective September 15, 2026; example labeling, not a product endorsement
  2. Povidone-iodine 0.5% sore throat gargle: Drug Facts. DailyMed / U.S. National Library of Medicine · ingredient monograph · SPL set ID 5f0a3377-1398-2603-c632-f0d214bb88ec; label checked October 15, 2026; no publication year inferred
  3. Widmer AF, Atkinson A, Kuster SP, et al.. Povidone Iodine vs Chlorhexidine Gluconate in Alcohol for Preoperative Skin Antisepsis: A Randomized Clinical Trial. JAMA (2024) · randomized trial · PMID 38884982; DOI 10.1001/jama.2024.8531; NCT03685604; primary abstract checked
  4. Viraldine, LLC: Warning Letter MARCS-CMS 625675. U.S. Food and Drug Administration (2022) · government guidance · March 7, 2022; specific nasal/throat products and COVID-19 claims; not a ban on every povidone-iodine use

Revision history

  1. Initial AI-assisted source checks and claim-level citation mapping under the site-authorized publishing workflow. No separate human or independent medical review is claimed.